Outset Medical, Inc. reaffirmed its previously provided guidance for 2024, including revenue of $145 million to $153 million, growing 12% to 18% over 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.63 USD | +9.58% | +12.39% | -51.39% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.39% | 136M | |
+8.69% | 220B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 107B | |
-0.46% | 63.05B | |
+12.72% | 51.74B | |
+3.96% | 50.47B | |
+0.40% | 40.91B | |
+15.03% | 40.59B |
- Stock Market
- Equities
- OM Stock
- News Outset Medical, Inc.
- Outset Medical, Inc. Reaffirms Earnings Guidance for 2024